Stockreport

Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory Update

RITTER PHARMACEUTICALS  (RTTR) 
Last ritter pharmaceuticals earnings: 8/14 05:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ritterpharmaceuticals.com/investors
PDF LOS ANGELES, June 20, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative thera [Read more]